Aggregate Asset Value: aimimmuno.com (AIM)
The market price on the GURU.Markets platform, as confirmed by this chart, shows that the total assets of AIM ImmunoTech (AIM) amount to 8.43. AIM ImmunoTech (AIM) develops immune-boosting agents, yet faces intense pressure from pharma behemoths in the competition for government funding. The business relies on foreign patents, which remain vulnerable due to political strife and raw material supply chain issues. Meanwhile, the company strictly adheres to environmental waste disposal regulations.
Financial and market metric breakdowns for AIM ImmunoTech (AIM)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Analysis of all company metrics:AIM ImmunoTech
As a biopharmaceutical innovator in the field of cancer and viral immunotherapy, AIM ImmunoTech (AIM) is accumulating resources, where the value of consolidated assets—reconstructed via daily ROA as the sum of equity and liabilities—objectively measures the scale of its operational base; for the investor, the trend of this metric serves as an indicator of the company's ability to sustain costly research and development amid tight monetary policy.
Competitor analysis for AIM ImmunoTech
argenx.com (ARGX) - Total Asset Value of Company|BNTX - Company Total Assets|Aggregate Asset Value Abivax|Company Total Assets ADMA|Company Total Assets PTGX (Protagonist Corp)|Aggregate Company Assets Immunovant, Inc.|kiniksa.com - Aggregate Asset Value|GRFS: Aggregate Company Assets|ADPT - Cumulative Company Assets|CLDX: Company Total Assets|Company Total Assets Aurinia Corp|BCRX - Cumulative Company Assets|Aggregate Asset Value veratx.com|DNTH (Dianthus Therapeutics, Inc.) - Company Total Assets|Company Total Asset Base PHVS (Pharvaris NV)|abcellera.com - Aggregate Company Assets|Tourmaline - Cumulative Company Assets|PGEN: Aggregate Company Assets|pharming.com (PHAR) - Cumulative Company Assets|NKTR: Cumulative Company Assets|UPB (Upstream Bio, Inc.) - Company Total Assets|Aggregate Company Assets Zenas Biopharma, Inc. (ZBIO)|Total Business Assets Immunome Bio|Gossamer Bio, Inc. - Company Total Assets|Company Assets kalvista.com (KALV)|Company Total Assets SEPN (Septerna)|Company Total Assets Pieris Pharma PVLA|Company Total Assets SVRA (Savara Corp)|RIGL: Company Total Asset Base|ANAB (AnaptysBio, Inc.) - Aggregate Company Assets|Cumulative Company Assets astriatx.com|ENGN - Cumulative Company Assets|Aggregate Asset Value RAPT Therapeutics Inc.|JBIO (Aerovate Therapeutics Inc) - Company Total Assets|Company Total Asset Base ACRS (Aclaris Therapeutics, Inc)|Kyverna Therapeutics - Aggregate Company Assets|tizianalifesciences.com - Cumulative Company Assets|CABA: Aggregate Company Assets|Ventyx Biosciences Inc. (VTYX) - Cumulative Company Assets|THTX: Cumulative Company Assets|AVTX (Avalo Therapeutics Inc) - Company Total Assets|Aggregate Company Assets Eledon Pharmaceuticals (ELDN)|Total Business Assets AGEN|Climb Bio - Aggregate Company Assets|Company Assets Zura Bio Ltd ZURA|Cumulative Company Assets aTyr (ATYR)|Aggregate Business Assets Adagene Inc ADAG|IMA (Ikena Oncology, Inc.) - Company Total Assets|STTK - Company Assets|EQ (equilliumbio.com) - Company Total Assets|Connect Biopharma Holdings Limited (CNTB) - Cumulative Company Assets|IMUX - Company Total Assets|Aggregate Asset Value Atara Biotherapeutics Inc|Company Total Assets IFRX|Company Total Assets x4pharma.com (XFOR)|Company Total Assets ACET|Celularity Inc - Company Total Asset Base|INMB: Aggregate Company Assets|BRNS: Cumulative Company Assets|Aggregate Company Assets Kezar Life Sciences (KZR)|sabbiotherapeutics.com (SABS) - Total Asset Value of Company|AKTX - Company Total Assets|Aggregate Asset Value Enlivex Therapeutics, Ltd.|Company Total Assets QTTB|Company Total Assets GOVX (GeoVax Corp)|Aggregate Company Assets Edesa Biotech, Inc.|ibioinc.com - Aggregate Asset Value|CARM: Aggregate Company Assets|XTLB - Cumulative Company Assets|BOLT: Company Total Assets|Company Total Assets HCW Biologics|APVO - Cumulative Company Assets|Aggregate Asset Value Aditxt Corp|GRI (GRI Bio) - Company Total Assets|Company Total Asset Base XRTX (XORTX Therapeutics Inc)|ReShape Lifesciences - Aggregate Company Assets|Revelation Biosciences Corp - Cumulative Company Assets|INDP: Aggregate Company Assets|scinai.com (SCNI) - Cumulative Company Assets|CALI: Cumulative Company Assets|AFMD (Affimed N.V.) - Company Total Assets|Aggregate Company Assets Allakos Inc (ALLK)|Total Business Assets HOOKIPA|IGM Biosciences, Inc. - Company Total Assets|Company Assets iteostherapeutics.com (ITOS)|Company Total Assets OCEA (Ocean Biomedical)|Company Total Assets TC BioPharm (Holdings) Plc TCBP|Company Total Assets THRD (Third Harmonic Bio, Inc)